Organization
First Department of Medicine
3 abstracts
Abstract
Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and pembrolizumab in patients with immune checkpoint inhibitor-naive unresectable or metastatic melanoma: Updated results from IOV-COM-202 cohort 1A.Org: Orlando Health Cancer Institute, First Department of Medicine, National and Kapodistrian University of Athens, Cooper University Hospital, Norris Comprehensive Cancer Center,
Abstract
Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.Org: Genekor, Genekor Medical SA, Memorial and Medstar, Kent Hospital, Fundeni Clinical Institut,
Abstract
ASSOCIATIONS BETWEEN SERUM ANTI-CCP ANTIBODY, RHEUMATOID FACTOR LEVELS AND HLA-DR4 EXPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: Third Department of Medicine, Division of Clinical Immunology, Third Department of Medicine, Regional Immunology Laboratory, Third Department of Medicine, Division of Rheumatology, University of Debrecen Medical Center, Debrecen, Hungary, Laboratory of Immunology, College of Pharmacy, Seoul National University and Cellid, Inc., Rheumatology Division, First Department of Medicine, University of Debrecen Medical Center,